search
Back to results

Monocular Action Video Game Treatment of Amblyopia

Primary Purpose

Amblyopia, Amblyopia Occlusion, Unilateral Amblyopia

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Monocular Active Occlusion
Monocular Passive Occlusion
Sponsored by
Universitat Politècnica de Catalunya
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Amblyopia focused on measuring Action Video Games, Amblyopia treatment

Eligibility Criteria

4 Years - 10 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 4-10 years old
  • Anisometropic amblyopia
  • Strabismic amblyopia or mixed
  • Interocular visual acuity (VA) difference of at least 0.2 logMAR
  • No history of eye surgery

Exclusion Criteria:

  • Non-comitant and/or large constant strabismus (>30 prism diopters)
  • Any ocular pathological condition or nystagmus

Sites / Locations

  • Laura Asensio Jurado

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Passive Occlusion

Active Occlusion

Arm Description

This arm will include those participants who will follow a daily occlusive treatment of 2 hours.

This arm will include patients who will be treated with monocular therapy with video-games of one hour on a daily regimen.

Outcomes

Primary Outcome Measures

Change from baseline visual acuity (VA) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).
Visual Acuity (VA in logMAR) will be evaluated by E Snellen Test through an Ipad and the app AmblyopiaVA. The AmblyopiaVA test is designed based on the standard protocol for measuring Visual Acuity in children with Amblyopia.The measure will be performed at 2 m.
Change from baseline stereopsis (ST) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).
Stereopsis (ST in logMAR) will be evaluated by a Multiple Random Points test through an Ipad, the app StereoTAB and anaglyphic glasses. The measures will be performed at 50 cm.
Change from baseline contrast sensitivity function (CSF) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).
The effect of treatment on Contrast Sensitivity Function (CSF in logMAR) will be evaluated by ClinicCFS test using sine grids of four different spatial frequencies: 3, 6, 12 and 18 cpd.

Secondary Outcome Measures

Satisfaction assessed by an ordinal questionnaire designed based on the Treatment Satisfaction Questionnaire for Medication (TSQM).
Satisfaction assessed by an ordinal questionnaire (1 to 5, as 1 the lowest satisfaction and 5 the highest satisfaction),based on the TSQM (Treatment Satisfaction Questionnaire for Medication) version 1.4 to provide data regarding the degree of satisfaction and sensation of parents and children in relation to treatment.
Rate of Compliance comparing passive occlusion vs active occlusion (with action video games) assessed by Google Analytics and written questionnaire.
Rate of Compliance assessed through the registration of parent-reported adherence and log file data in Google Analytics (descriptive scale of time in hours/day) for active group and parent's questionnaire for passive group (subjective scale in hours/day)

Full Information

First Posted
March 8, 2020
Last Updated
March 22, 2023
Sponsor
Universitat Politècnica de Catalunya
Collaborators
Hospital Mutua de Terrassa, Parc Sanitari Sant Joan de Déu
search

1. Study Identification

Unique Protocol Identification Number
NCT04313257
Brief Title
Monocular Action Video Game Treatment of Amblyopia
Official Title
Monocular Action Video Game Versus Passive Occlusion In The Treatment Of Amblyopia: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
September 17, 2019 (Actual)
Primary Completion Date
January 16, 2023 (Actual)
Study Completion Date
January 16, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitat Politècnica de Catalunya
Collaborators
Hospital Mutua de Terrassa, Parc Sanitari Sant Joan de Déu

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments.
Detailed Description
Amblyopia is the condition in which there is a decrease in monocular visual acuity or, less frequently, binocular, in absence of structural anomalies or ocular pathology. It is a reversible condition that affects up to 5% of the population, and that is the result of an abnormal visual experience during the most sensitive period of visual development. The aim of this study is reviewing, analyzing and, if applicable, updating the current treatment model for amblyopia. A randomized clinical trial will be performed to evaluate the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments. The participants will be distributed in two groups. The first group will include those participants who will follow a daily occlusive treatment and the second group will include patients who will be treated with monocular therapy with video-games.The sample will include subjects between 4 to 10 years old with a diagnosis of refractive and / or strabismic amblyopia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Amblyopia, Amblyopia Occlusion, Unilateral Amblyopia, Anisometropic Amblyopia, Strabismic Amblyopia
Keywords
Action Video Games, Amblyopia treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized clinical trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Passive Occlusion
Arm Type
Active Comparator
Arm Description
This arm will include those participants who will follow a daily occlusive treatment of 2 hours.
Arm Title
Active Occlusion
Arm Type
Experimental
Arm Description
This arm will include patients who will be treated with monocular therapy with video-games of one hour on a daily regimen.
Intervention Type
Other
Intervention Name(s)
Monocular Active Occlusion
Intervention Description
Occlusion treatment of one hour daily with action video game.
Intervention Type
Other
Intervention Name(s)
Monocular Passive Occlusion
Intervention Description
Occlusion treatment of two hour daily.
Primary Outcome Measure Information:
Title
Change from baseline visual acuity (VA) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).
Description
Visual Acuity (VA in logMAR) will be evaluated by E Snellen Test through an Ipad and the app AmblyopiaVA. The AmblyopiaVA test is designed based on the standard protocol for measuring Visual Acuity in children with Amblyopia.The measure will be performed at 2 m.
Time Frame
Baseline and 14, 28 and 42 hours post treatment.
Title
Change from baseline stereopsis (ST) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).
Description
Stereopsis (ST in logMAR) will be evaluated by a Multiple Random Points test through an Ipad, the app StereoTAB and anaglyphic glasses. The measures will be performed at 50 cm.
Time Frame
Baseline and 14, 28 and 42 hours post treatment.
Title
Change from baseline contrast sensitivity function (CSF) at 14 hours , 28 hours , and 42 hours comparing passive occlusion vs active occlusion (with action video games).
Description
The effect of treatment on Contrast Sensitivity Function (CSF in logMAR) will be evaluated by ClinicCFS test using sine grids of four different spatial frequencies: 3, 6, 12 and 18 cpd.
Time Frame
Baseline and 14, 28 and 42 hours post treatment.
Secondary Outcome Measure Information:
Title
Satisfaction assessed by an ordinal questionnaire designed based on the Treatment Satisfaction Questionnaire for Medication (TSQM).
Description
Satisfaction assessed by an ordinal questionnaire (1 to 5, as 1 the lowest satisfaction and 5 the highest satisfaction),based on the TSQM (Treatment Satisfaction Questionnaire for Medication) version 1.4 to provide data regarding the degree of satisfaction and sensation of parents and children in relation to treatment.
Time Frame
42 hours
Title
Rate of Compliance comparing passive occlusion vs active occlusion (with action video games) assessed by Google Analytics and written questionnaire.
Description
Rate of Compliance assessed through the registration of parent-reported adherence and log file data in Google Analytics (descriptive scale of time in hours/day) for active group and parent's questionnaire for passive group (subjective scale in hours/day)
Time Frame
Baseline and 14h, 28h and 42 hours.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
10 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 4-10 years old Anisometropic amblyopia Strabismic amblyopia or mixed Interocular visual acuity (VA) difference of at least 0.2 logMAR No history of eye surgery Exclusion Criteria: Non-comitant and/or large constant strabismus (>30 prism diopters) Any ocular pathological condition or nystagmus
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laura Asensio Jurado, MsC
Organizational Affiliation
Universitat Politècnica de Catalunya
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Marc Argilés Sans, PhD
Organizational Affiliation
Universitat Politècnica de Catalunya
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Lluïsa Quevedo i Junyent, PhD
Organizational Affiliation
Universitat Politècnica de Catalunya
Official's Role
Study Director
Facility Information:
Facility Name
Laura Asensio Jurado
City
Barcelona
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
22715883
Citation
Bavelier D, Green CS, Pouget A, Schrater P. Brain plasticity through the life span: learning to learn and action video games. Annu Rev Neurosci. 2012;35:391-416. doi: 10.1146/annurev-neuro-060909-152832.
Results Reference
background
PubMed Identifier
21912514
Citation
Li RW, Ngo C, Nguyen J, Levi DM. Video-game play induces plasticity in the visual system of adults with amblyopia. PLoS Biol. 2011 Aug;9(8):e1001135. doi: 10.1371/journal.pbio.1001135. Epub 2011 Aug 30.
Results Reference
background
PubMed Identifier
29172564
Citation
Bediou B, Adams DM, Mayer RE, Tipton E, Green CS, Bavelier D. Meta-analysis of action video game impact on perceptual, attentional, and cognitive skills. Psychol Bull. 2018 Jan;144(1):77-110. doi: 10.1037/bul0000130. Epub 2017 Nov 27. Erratum In: Psychol Bull. 2018 Sep;144(9):978-979.
Results Reference
background
PubMed Identifier
29709618
Citation
Gambacorta C, Nahum M, Vedamurthy I, Bayliss J, Jordan J, Bavelier D, Levi DM. An action video game for the treatment of amblyopia in children: A feasibility study. Vision Res. 2018 Jul;148:1-14. doi: 10.1016/j.visres.2018.04.005. Epub 2018 May 12.
Results Reference
background

Learn more about this trial

Monocular Action Video Game Treatment of Amblyopia

We'll reach out to this number within 24 hrs